David Roman's Stock Ratings

Goldman Sachs Analyst

David Roman is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 11/15/2024

Overall Average Return

-%

Smart Score

44.3%

Overall Average Return Percentile

-

Number of Ratings

21
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
The Analyst Verdict: Tandem Diabetes Care In The Eyes Of 5 Experts
Forecasting The Future: 6 Analyst Projections For iRhythm Technologies
Intuitive Surgical Posts Q3 Earnings Beat, These Analysts Raise Forecasts On DV5 Uptake
Intuitive Surgical (NASDAQ: ISRG) reports strong Q3 earnings. Analysts raise price targets and are bullish on future growth.
Beyond The Numbers: 9 Analysts Discuss iRhythm Technologies Stock
LivaNova's New Strategy Could Unlock Revenue, Profit Gains, Analyst Predicts
LivaNova gets Buy rating from Goldman Sachs analyst. $65 PT. The company appears poised for consistent revenue growth in its base business.
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
A Closer Look at 25 Analyst Recommendations For Edwards Lifesciences
Beyond The Numbers: 6 Analysts Discuss Baxter Intl Stock
Decoding 4 Analyst Evaluations For Solventum
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved